Skip to main content

Catecholamines in Activation, Stereotypy, and Level of Mood

  • Chapter
Catecholamines and Behavior · 1

Abstract

Studies of the effects of psychoactive drugs have contributed much to the present knowledge of the role of catecholamines in behavioral physiology. Since drugs are never completely specific, i.e., no drug acts on only one system in the brain, the knowledge derived from pharmacological experiments is beset with a corresponding uncertainty. Evidence from several experiments, preferably carried out using very different methods, is therefore necessary for conclusions about association between a specific system in the brain and a certain behavior. In the following we shall try to expound such evidence about the association of catecholaminergic systems in the brain with behavioral activation and stereotypy, and we shall explore the possible relations of animal experiments with clinical observations comprising also mental phenomena such as thinking and mood.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alarcon, R. de, and Carney, M. W. P., 1969, Severe depressive mood changes following slow-release intramuscular fluphenazine injection, Brit. Med. J. 3: 564.

    PubMed  Google Scholar 

  • Anggàrd, E., Jönsson, L. E., and Gunne, L.-M., 1971, Pharmacological blockade of amphetamine effects in subjects dependent on central stimulants, Acta Pharmacol. Toxicol. Suppl. 4: 2.

    Google Scholar 

  • Angrist, B., 1974, Amphetamine Psychosis, in: Catecholamines and Their Enzymes in the Neuropathology of Schizophrenia (S. Kety and S. Matthysse, eds.), J. Psychiat. Res. 11: 1.

    Google Scholar 

  • Angrist, B., Schweitzer, J., Friedhoff, A. J., Gershon, S., Hekimian, L. J., and Floyd, A., 1969, The clinical symptomatology of amphetamine psychosis and its relationship to amphetamine levels in urine, Int. Pharmacopsychiatry 2:125.

    Google Scholar 

  • Anlezark, G. M., Arbuthnott, G. W., Christie, J. E., and Crow, T. J., 1971, Role of cerebral dopamine in action of psychotropic drugs, Brit. J. Pharmacol. 41: 406.

    Google Scholar 

  • Arnfred, T., and Randrup, A., 1968, Cholinergic mechanism in brain inhibiting amphetamine-induced stereotyped behavior, Acta Pharmacol. Toxicol. 26: 384.

    CAS  Google Scholar 

  • Ashcroft, G. W., et al., 1972, Modified amine hypothesis for the etiology of affective illness, Lancet 1972: 573.

    Google Scholar 

  • Ayhan, I. H., and Randrup, A., 1972, Role of brain noradrenaline in morphine-induced stereotyped behavior, Psychopharmacologia 27: 203.

    PubMed  CAS  Google Scholar 

  • Ayhan, I. H., and Randrup, A., 1973a, Behavioral and pharmacological studies on morphine-induced excitation of rats. Possible relation to brain catecholamines, Psychopharmacologia 29: 317.

    PubMed  CAS  Google Scholar 

  • Ayhan, I. H., and Randrup, A., 1973b, Inhibitory effects of amphetamine, L-dopa and apomorphine on morphine-induced behavioral excitation of rats, Arch. Intern. Pharmacodyn. 204: 283.

    CAS  Google Scholar 

  • Benkert, 0., 1969, Measurement of hyperactivity in rats in a dose-response curve after intrahypothalamic norepinephrine injection, Life Sci. 8: 943.

    Google Scholar 

  • Bleuler, M., 1972, Lehrbuch der Psychiatrie, Springer-Verlag, Berlin, Heidelberg, New York. Boardman, R. H., and Fullerton, A. G., 1960, Iatrogenic parkinsonism, J. Mental Sci. 106: 1468.

    Google Scholar 

  • Bobon, J., Pinchard, A., Collard, J., and Bobon, D. P., 1972, Clinical classification of neuroleptics, with special reference to their antimanic, antiautistic, and ataraxic properties. Comprehensive Psychiat. 13: 123.

    CAS  Google Scholar 

  • Bobon, J., Bobon, D. P., Pinchard, A., Collard, J., Ban, T. A., Buck, R. de, Hippius, H., Lambert, P. A., and Vinar, O., 1972a, A new comparative physiognomy of neuroleptics: a collaborative clinical report. Acta Psychiat. Belgica 72: 542.

    CAS  Google Scholar 

  • Bohaeek, N., 1965, Discussion working group 4, in: Neuro-Psychopharmacology, ( D. Bente and P. B. Bradley, eds.), pp. 175–178, Elsevier Publishing Company, Amsterdam.

    Google Scholar 

  • Bowers, M. B., Jr., 1973, 5-Hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) following probenecid in acute psychotic patients treated with phenothiazines, Psychopharmacologia 28: 309.

    Google Scholar 

  • Caine, D. B., 1970, L-Dopa in the treatment of parkinsonism, Clin. Pharmacol. Therap. 11: 6.

    Google Scholar 

  • Carlsson, A., Persson, T., Roos, B. E., and Wâlinder, J., 1972, Potentiation of phenothiazines by a-methyltyrosine in treatment of chronic schizophrenia, J. Neural Transmission 33: 83.

    CAS  Google Scholar 

  • Carroll, B. J., and Sharp, P. T., 1972a, Monoamine mediation of the morphine-induced activation of mice, Brit. J. Pharmacol. 46: 124.

    CAS  Google Scholar 

  • Carroll, B. J., and Sharp, P. T., 1972b, An animal model of mania, Psychopharmacologia 26 (Suppl. 1972): 10.

    Google Scholar 

  • Cole, J. O., and Davis, J. M., 1968, Clinical efficacy of the phenothiazines as antipsychotic drugs, in: Psychopharmacology, (D. H. Efron, ed.), pp. 1057–1063, Public Health Service Publ. No. 1836, U.S. Government, Printing Office, Washington, D.C.

    Google Scholar 

  • Connell, P. H., 1956, Amphetamine psychosis, Thesis, Maudsley Hospital, University of London.

    Google Scholar 

  • Cools, A. R., 1971, The function of dopamine and its antagonism in the caudate nucleus of cats in relation to the stereotyped behaviour, Arch. Intern. Pharmacodyn, 194: 259.

    CAS  Google Scholar 

  • Cools, A. R., 1973, The Caudate Nucleus and Neurochemical Control of Behavior, Thesis, Universitet Nijmegen, Holland.

    Google Scholar 

  • Costall, B. and Naylor, R. J., 1974, Extrapyramidal and mesolimbic involvement with the stereotypic activity of d-and 1-amphetamine, European J. Pharmacol. 25: 121.

    CAS  Google Scholar 

  • Crow, T. J., 1972, A map of the rat mesencephalon for electrical self-stimulation, Brain Res. 36: 265.

    PubMed  CAS  Google Scholar 

  • Daube, H., 1942, Pervitinpsychosen, Nervenarzt 15: 20.

    Google Scholar 

  • Delay, J., Pichot, P., Lemperiere, T., and Bailly, R., 1963, L’emploi des butyrophenones en psychiatrie etude statistique et psychometrique, in: Symposium Internazionale Sull’Haloperido! E Triperidol, pp. 305-319, Istituto Luso Farmaco D’Italia, Milano.

    Google Scholar 

  • Dyne, L. J., and Hughes, R. N., 1970, Effects of methylphenidate on activity and reactions to novelty in rats, Psychonomic Sci. 19 (5): 267.

    Google Scholar 

  • Ellinwood, E. H., 1967, Amphetamine psychosis: I. Description of the individuals and process, J. Nervous Mental Disease 144: 273.

    Google Scholar 

  • Ellinwood, E. H., 1969, Amphetamine psychosis: A multi-dimensional process, Seminars Psychiatry 1: 208.

    Google Scholar 

  • Ellinwood, E. H., 1971, Comparative methamphetamine intoxication in experimental animals, Pharmakopsychiat. Neuropsychopharmakol. 4: 357.

    Google Scholar 

  • Ellinwood, E. H. 1972, Amphetamine psychosis: individuals, setting, and sequences, in: Current Concepts of Amphetamine Abuse,(E. H. Ellinwood, and S. Cohen, eds.), pp. 143–157, U.S. Government Printing Office, Washington, D.C.

    Google Scholar 

  • Ellinwood, E. H., and Cohen, S. (eds.), 1972, Current Concepts of Amphetamine Abuse, U.S. Government Printing Office, Washington, D.C.

    Google Scholar 

  • Ellinwood, E. H., and Duarte-Escalante, 0., 1972, Chronic methamphetamine intoxication in three species of experimental animals, in: Current Concepts of Amphetamine Abuse, ( E. H. Ellinwood and S. Cohen, eds.), pp. 59–68, U.S. Government Printing Office, Washington, D.C.

    Google Scholar 

  • Ellinwood, E. H., Sudilovsky, and Nelson, L. M., 1973, Evolving behavior in the clinical and experimental amphetamine (model) psychosis, Am. J. Psychiat. 730 (10): 1088.

    Google Scholar 

  • Ernst, A. M., 1971, Chemical stimulation of central dopaminergic receptors in the striatal body of rats, in: The Correlation of Adverse Effects in Man with Observation in Animals (S. B. de Baker, ed.), pp. 18–23, Excerpta Med. Intern. Congr. Series 220, Amsterdam.

    Google Scholar 

  • Ernst, A. M., 1972, Relationship of the central effect of dopamine on gnawing compulsion syndrome in rats and the release of serotonin, Arch. Intern. Pharmacodyn. 199: 219.

    CAS  Google Scholar 

  • Fog, R., 1970, Behavioral effects in rats of morphine and amphetamine and of a combination of the two drugs, Psychopharmacologia 16: 305.

    PubMed  CAS  Google Scholar 

  • Fog, R., 1972, On stereotype and catalepsy: studies on the effect of amphetamines and neuroleptics in rats, Acta Neurol. Scand. Suppl. 48: 50 (Thesis).

    Google Scholar 

  • Forrest, A., 1969, Depressive changes after fluphenazine treatment, Brit. Med. J. October:69. Fukui, K., and Tagaki, H., 1972, Effect of morphine on the cerebral contents of metabolites of dopamine in normal and tolerant mice: its possible relation to analgesic action, Brit. J. Pharmacol. 44: 45.

    Google Scholar 

  • Fukui, K., Shiomi, H., and Tagaki, H., 1972, Effect of morphine on tyrosine hydroxylase activity in mouse brain, European J. Pharmacol. 19: 123.

    CAS  Google Scholar 

  • Geyer, M., 1973, Dissociation of some behavioral effects of intraventricular dopamine and norepinephrine, Dissertation Abst. 33 (11): 5539.

    Google Scholar 

  • Geyer, M. A., and Segal, D. S., 1973, Differential effects of reserpine and a-methyl-p-tyrosine on norepinephrine and dopamine induced behavioral activity, Psychopharmacologia 29: 131.

    PubMed  CAS  Google Scholar 

  • Goodwin, F. K., Post, R. M., Dunner, D. L., and Gordon, E. K., 1973, Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique, Am. J. Psychiat. 130 (1): 73.

    PubMed  CAS  Google Scholar 

  • Guinard, L., 1890, Action physiologique de la morphine chez le chat, C. R. Acad, Sci. (Paris) 111: 981.

    Google Scholar 

  • Gunne, L. M., Änggârd, E., and Jönsson, L. E., 1970, Blockade of amphetamine effects in human subjects, in: International Institute on the Prevention and Treatment of Drug De pendence, I.C.A.A. ( A. Tongue and E. Tongue, eds.), pp. 249–255, Lausanne, Switzerland.

    Google Scholar 

  • Gunne, L. M.,.Änggârd, E., and Jönsson, L. E., 1972, Clinical trials with amphetamine-blocking drugs. Psychiat. Neurol. Neurochir. 75: 225.

    CAS  Google Scholar 

  • Harder, A., 1947, Uber Weckamin-Psychosen, Schweiz. Med. Wochschr. 37/38:982. Heimchen, H., and Hippius, H., 1967, Depressive Syndrome im Verlauf neuroleptischer Therapie, Nervenarzt 38 (10): 455.

    Google Scholar 

  • Herman, Z. S., 1970, The effects of noradrenaline on rat’s behaviour, Psychopharmacologia 16: 369.

    PubMed  CAS  Google Scholar 

  • Hughes, R. N., 1972, Methylphenidate-induced inhibition of exploratory behaviour in rats, Life Sci. 11: 161.

    CAS  Google Scholar 

  • Isbell, H., 1971, Clinical aspects of the various forms of nonmedical use of drugs, Anesthesia Analgesia Current Res. 50: 886.

    CAS  Google Scholar 

  • Janssen, P. A. J., Niemegeers, C. J. E., and Schellekens, K. H. L., 1965, Is it possible to predict the clinical effects of neuroleptic drugs (major tranquilizers) from animal data? I. A rzneimit tel-Forsch. 15: 104.

    CAS  Google Scholar 

  • Janssen, P. A. J., Niemegeers, C. J. E., Schellekens, K. H. L., and Lenaerts, F. M., 1967, Is it possible to predict the clinical effects of neuroleptic drugs (major tranquilizers) from animal data? IV, Arzneimittel-Forsch. 17: 841.

    CAS  Google Scholar 

  • Jönsson, L. E., Änggârd, E., and Gunne, L.-M., 1971, Blockade of intravenous amphetamine euphoria in man, Clin. Pharmacol. Therap. 12: 889.

    Google Scholar 

  • Kalus, F., 1950, Über die psychotischen Bilder bei chronischem Pervitinmissbrauch (II), Psychiat. Neurol. Med. Psychol. 2:138:

    Google Scholar 

  • Kalus, F.; Kucher, I., and Zutt, J., 1942, Über Psychosen bei chronisher Pervitinmissbrauch, Nervenarzt 15: 8.

    Google Scholar 

  • Kellner, E., 1960, Preludinsucht and Preludinpsychose, Ther. Ggw. 11: 524.

    Google Scholar 

  • Kety, S., and Matthysse, S. (eds.), 1974, Catecholamines and their enzymes in the Neuropathology of Schizophrenia, J. Psychiatric Res. 11:1.

    Google Scholar 

  • Kjellberg, B., and Randrup, A., 1971, The effects of amphetamine and pimozide, a neuroleptic, on the social behavior of vervet monkeys (ceropithecus sp), in: Advances in Neuro-Psychopharmacology, ( O. Vinai, Z. Votava, and P. B. Bradley, eds.), pp. 305–310, North-Holland Publishing Company, Amsterdam. Avicenum, Czechoslovak Medical Press, Prague.

    Google Scholar 

  • Kjellberg, B., and Randrup, A., 1972a, Stereotypy with selective stimulation of certain items of behavior observed in amphetamine-treated monkeys (cercopithecus), Pharmakopsychiatr. Neuropsychopharmakol. 5: 1.

    CAS  Google Scholar 

  • Kjellberg, B., and Randrup, A., 1972b, Changes in social behaviour in pairs of vervet monkeys (cercopithecus) produced by single, low doses of amphetamine, Psychopharmacologia Suppl. 26: 117.

    Google Scholar 

  • Krueger, H., Eddy, N. B., and Sumwalt, M., 1941, The Pharmacology of the Opium Alkaloids, Part 1, Supplement 165, Public Health Reports, U.S. Government Printing Office, Washington, D.C.

    Google Scholar 

  • Kuschinsky, K., and Hornykiewicz, 0., 1973, Morphine-induced locomotor activity in mice: involvement of central dopaminergic and noradrenergic neurons, in: IV Congress of the Polish Pharmacological Society ( Kuschinsky, K., and Hornykiewicz, 0., ed.), p. 27, Lodz.

    Google Scholar 

  • Lat, J., 1965, The spontaneous exploratory reactions as a tool for psychopharmacological studies. A contribution towards a theory of contradictory results, in: Pharmacology of Conditioning, Learning and Retension ( M. Ya. Mikhel’son, V. G. Longo, and Z. Votava, eds.), pp. 47–66, Pergamon Press, Czechoslovak Medical Press, Prague.

    Google Scholar 

  • Lyon, M., and Randrup, A., 1972, The dose-response effect of amphetamine upon avoidance behavior in the rat seen as a function of increasing stereotype, Psychopharmacologia 23: 334.

    PubMed  CAS  Google Scholar 

  • Mandell, A. J., Markham, C. H., Tallman, F. F., and Mandell, M. P., 1962, Motivation and ability to move, Am. J. Psychiat. 119: 554.

    Google Scholar 

  • McKenzie, G. M., 1972, Role of the tuberculum olfactorium in stereotyped behavior induced by apomorphine in the rat, Psychopharmacologia 23: 212.

    PubMed  CAS  Google Scholar 

  • Mendels, J., Frazer, A., Fitzgerald, R. G., Ramsey, T. A., and Stokes, J. W., 1972, Biogenic amine metabolites in cerebrospinal fluid of depressed and manic patients, Science 175:1380.

    Google Scholar 

  • Mindham, R. H. S., 1970, Psychiatric symptoms in Parkinsonism, J. Neurol. Neurosurg. Psychiat. 33: 188.

    PubMed  CAS  Google Scholar 

  • Müller-Calgan, H., and Hotovy, R., 1961, Verhaltensänderungen der Katze durch verschiedene zentralerregand wirkende Pharmaka, Arzneimittel-Forsch. 11: 642.

    Google Scholar 

  • Müller-Fahlbusch, H., 1972, Klinische and Katamnestische Untersuchungen zum Parkinsonismus, Georg Thieme Verlag, Stuttgart.

    Google Scholar 

  • Munkvad, I., and Randrup, A., 1966, The persistence of amphetamine stereotypies of rats in spite of strong sedation, Acta Psychiat. Scand. Suppl. 191: 178.

    CAS  Google Scholar 

  • Munkvad, I., and Randrup, A., 1970, Evidence indicating the role of brain dopamine in the psychopharmacology of schizophrenic psychoses, in: PsihoJarmakologija 2 ( N. Bohacek, ed.), pp. 45–47, Medicinska Naklada, Zagreb.

    Google Scholar 

  • Munkvad, I., Hein, G., and Herskin, B., 1971, The treatment of chronic schizophrenics with pimozide (Orap), Clin. Trials J. 8 (Suppl. II): 67.

    Google Scholar 

  • Nielsen, E. B., and Lyon, M., 1973, Drinking behavior and brain dopamine: Antagonistic effect of a neuroleptic drug (Pimozide) upon amphetamine-or apomorphine-induced hypodipsia, Psychopharmacologia 33: 299.

    PubMed  CAS  Google Scholar 

  • Nordin, G., Ottosson, J.-O., and Ross, B.-E., 1971, Influence of convulsive therapy on 5hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid in endogeneous depression, Psychopharmacologia 20: 315.

    PubMed  CAS  Google Scholar 

  • Norton, S., 1967, An analysis of cat behaviour using chlorpromazine and amphetamine, Intern J. Neuropharmacol. 6: 307.

    CAS  Google Scholar 

  • Nymark, M., 1972, Apomorphine provoked stereotypy in the dog, Psychopharmacologia 26: 361.

    PubMed  CAS  Google Scholar 

  • O’Flanagan, P. M., and Taylor, R. B., 1950, A case of recurrent psychosis associated with amphetamine addiction, J. Mental Sci. 96: 1033.

    Google Scholar 

  • Papeschi, R., and McClure, D., 1971, Homovanillic and 5-hydroxyindoleacetic acid in cerebrospinal fluid of depressed patients. Arch. Gen. Psychiat. 25: 352.

    Google Scholar 

  • Papeschi, R., Randrup, A., and Lal, S., 1974a, Effect of ECT on dopaminergic and noradrenergic mechanisms. I. Effect on the behavioral changes induced by reserpine, a-methyl-ptyrosine or amphetamie, Psychopharmacologia 35: 149.

    PubMed  CAS  Google Scholar 

  • Papeschi, R., Randrup A., and Munkvad, I., 19746, Effect of ECT on dopaminergic and noradrenergic mechanisms. II. Effect on dopamine and noradrenaline concentrations and turnovers, Psychopharmacologia 35:159.

    Google Scholar 

  • Patrick, H. T., and and Levy, D. M., 1922, Parkinson’s disease, Arch. Neurol. Psychiat. 7: 711.

    Google Scholar 

  • Pedersen, V., and Christensen, A. V., 1972, Antagonism of methyl-phenidate-induced stereotyped gnawing in mice, Acta Pharmacol. Toxicol. 31: 488.

    CAS  Google Scholar 

  • Piaget, J., 1964, Six Etudes de Psychologie, Gonthier, Paris.

    Google Scholar 

  • Post, R. M., Kotin, J., Goodwin, F. K., and Gordon, E. K., 1973, Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness, Am. J. Psychiat. 130 (1): 67.

    PubMed  CAS  Google Scholar 

  • Randrup, A., and Munkvad, I., 1965, Special antagonism of amphetamine-induced abnormal behaviour, Psychopharmacologia 7: 416.

    PubMed  CAS  Google Scholar 

  • Randrup, A., and Munkvad, I., 1967, Stereotyped activities produced by amphetamine in several animal species and man, Psychopharmacologia 11: 300.

    PubMed  CAS  Google Scholar 

  • Randrup, A., and Munkvad, I., 1968, Behavioural stereotypies induced by pharmacological agents, Pharmakopsychiat. Neuropsychopharmakol. 1: 18.

    Google Scholar 

  • Randrup, A., and Munkvad, I., 1970, Biochemical, anatomical and psychological investigations of stereotyped behavior induced by amphetamine, in: Amphetamines and Related Compounds ( E. Costa and S. Garattini, eds.), pp. 695–713, Raven Press, New York.

    Google Scholar 

  • Randrup, A., and Munkvad, I., 1971, Behavioural toxicity of amphetamine studied in animal experiments, in: The Correlation of Adverse Effects in Man with Observations in Animals (S. B. de Baker, ed.), pp. 6–16, Excerpta Med. Congr. Series No. 220, Amsterdam.

    Google Scholar 

  • Randrup, A., and Munkvad, I., 1972, Evidence indicating an association between schizophrenia and dopaminergic hyperactivity in the brain, Orthomol. Psychiat. 1 (1): 2.

    Google Scholar 

  • Randrup, A., and Munkvad, I., 1975, Stereotyped behavior, in: Section 25, International Encyclopedia of Pharmacology and Therapeutics (O. Hornykiewicz, ed.), Pergamon Press, Toronto (in press).

    Google Scholar 

  • Randrup, A., and Munkvad, I., 1974, Pharmacology and physiology of stereotyped behavior, in: Catecholamines and Their Enzymes in the Neuropathology of Schizophrenia (S. Kety and S. Matthysse, eds.)J. Psychiatric Res. 11 :1.

    Google Scholar 

  • Randrup, A., Munkvad, I., and Udsen, P., 1963, Adrenergic mechanisms and amphetamine-induced abnormal behaviour, Acta Pharmacol. Toxicol. 20: 145.

    CAS  Google Scholar 

  • Randrup, A., Munkvad, I. and Scheel-Krüger, J., 1973, Mechanisms by which amphetamines produce stereotypy, aggression and other behavioural effects, in: Psychopharmacology, Sexual Disorders and Drug Abuse (T. Bau et al.,eds.), North Holland, Amsterdam, and Avicenum, Prague.

    Google Scholar 

  • Robbins, T., and Iversen, S. D., 1973, A dissociation of the effects of d-amphetamine on loco-motor activity and exploration in rats, Psychopharmacologia 28: 155.

    PubMed  CAS  Google Scholar 

  • Robinson, P., and Daley, M., 1967, Apomorphine-induced reinforcement, Psychonomic Sci. 7: 117.

    Google Scholar 

  • Roffler-Tarlov, S., Sharman, D. F., and Tegerdine, P., 1971, 3,4-Dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the mouse striatum: a reflection of intra-and extra-neuronal metabolism of dopamine?, Brit. J. Pharmacol. 42: 343.

    Google Scholar 

  • Rolinski, Z., and Scheel-Krüger, J., 1973, The effect of dopamine and noradrenaline antagonists on amphetamine induced locomotor activity in mice and rats, Acta Pharmacol. Toxicol. 33: 385.

    CAS  Google Scholar 

  • Roos, B. E., and Sjöström, R., 1969, 5-hydroxyindoleacetic acid (and homovanillic acid) levels in the cerebrospinal fluid after probenecid application in patients with manic-depressive psychosis, Pharmacol. Clin. 1: 153.

    Google Scholar 

  • Rylander, G., 1969, Clinical and medico-criminological aspects of addition to central stimulating drugs, in: Abuse of Central Stimulants ( F. Sjoquist and M. Tottie, eds.), pp. 251–273, Almqvist and Wiksell, Stockholm.

    Google Scholar 

  • Rylander, G., 1971, Stereotypy in man following amphetamine abuse, in: The Correlation of Adverse Effects in Man with Observations in Animals (S. B. de Baker, ed.), pp. 28–31, Excerpta Med. Internl. Congr. Series No. 220, Amsterdam.

    Google Scholar 

  • Rylander, G., 1972, Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs, Psychiat. Neurol. Neurochir. 75: 203.

    PubMed  CAS  Google Scholar 

  • Sano, I., and Nagasaka, 1956, Uber chronische Weckaminsucht in Japan, Fortschr. Neurol. Psychiat. 24: 391.

    PubMed  CAS  Google Scholar 

  • Sayers, A. C., 1972, An investigation into hyperkinesia and akinesia induced by certain stimulant drugs, Thesis, University of Aston in Birmingham.

    Google Scholar 

  • Scheel-Krüger, J., 1972, Behavioural and biochemical comparison of amphetamine derivatives

    Google Scholar 

  • cocaine, benztropine and tricyclic antidepressant drugs, European J. Pharmacol. 18:63. Scher, J., 1966, Patterns and profiles of addiction and drug abuse, Arch. Gen. Psychiat. 15:539.

    Google Scholar 

  • Schi¢rring, E., 1971, Amphetamine-induced selective stimulation of certain behaviour items with concurrent inhibition of others in an open-field test with rats, Behaviour 34: 1.

    Google Scholar 

  • Schigrring, E., 1972, Social isolation and other behavioural changes in a group of three vervet monkeys (cercopithecus) produced by single, low doses of amphetamine, Psychopharmacologia Suppl. 26: 117.

    Google Scholar 

  • Schi¢rring, E., An open-field study on spontaneous locomotion with amphetamine-treated rats, In preparation.

    Google Scholar 

  • Schi¢rring, E., and Randrup, A., 1971, Social isolation and changes in the formation of groups induced by amphetamine in an open-field test with rats, Pharmakopsychiatr. Neuropsychopharmakol. 4: 2.

    Google Scholar 

  • Segal, D. S., and Mandell, A. J., 1970, Behavioral activation of rats during intraventricular infusion of norepinephrine, Proc. Natl. Acad. Sci. (U.S.) 66: 289.

    CAS  Google Scholar 

  • Segal, M., and Ropschitz, D., 1969, Depressive changes after fluphenazine treatment, Brit. Med. J. 3: 169.

    Google Scholar 

  • Simonson, M., 1964, Phenothiazine depressive reaction, J. Neuropsychiat. 5: 259.

    PubMed  CAS  Google Scholar 

  • Sjöqvist, F., and Tottie, M., (eds.), 1969, Abuse of Central Stimulants, Almqvist and Wiksell, Stockholm.

    Google Scholar 

  • Sjöström, R., 1972, Studier av mano-depressiv psykos, Forskning och Praktik (Sandoz) 4:102. Soudijn, W., and Wijngaarden, I. van, 1972, Localization of [3H]pimozide in the rat brain in relation to its anti-amphetamine potency, J. Pharm. Pharmacol. 24: 773.

    Google Scholar 

  • Staehelin, J. E., 1941, Pervitin-Psychose, Z. Ges. Neurol. Psychiat. 173: 589.

    Google Scholar 

  • Tatetsu, S., 1960, Pervitin-psychosen, Folia Psychiat. Neurol. Japon. Suppl. 6: 25.

    Google Scholar 

  • Van, Praag, H. M., and Korf, J., 1971, Retarded depression and the dopamine metabolism, Psychopharmacologia 19: 199.

    Google Scholar 

  • Warburton, J. W., 1967, Depressive symptoms in Parkinson patients referred for thalamotomy, J. Neurol. Neurosurg. Psychiat. 30: 368.

    PubMed  CAS  Google Scholar 

  • Willner, J. H., Samach, M., Angrist, B. M., Wallach, M. B., and Gershon, S., 1970, Drug-induced stereotyped behavior and its antagonism in dogs, Commun. Behay. Biol. 5: 135.

    Google Scholar 

  • York, D. H., 1972, Dopamine receptor blockage—A central action of chloropromazine on striatal neurones, Brain Res. 37: 91.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1975 Plenum Press, New York

About this chapter

Cite this chapter

Randrup, A., Munkvad, I., Fog, R., Ayhan, I.H. (1975). Catecholamines in Activation, Stereotypy, and Level of Mood. In: Friedhoff, A.J. (eds) Catecholamines and Behavior · 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3135-3_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-3135-3_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-3137-7

  • Online ISBN: 978-1-4684-3135-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics